Fox Chase Cancer Center
Recent News About Fox Chase Cancer Center View More
-
Local excision may benefit more rectal cancer patients, Fox Chase study shows
Fox Chase Cancer Center researchers presented a study at the Society of Surgical Oncology 2025 Annual Meeting, indicating that chemotherapy followed by local excision could be a viable treatment for patients with node-negative low rectal cancer.
-
Fox Chase study: removing more lymph nodes improves colon cancer surgery outcomes
Removing and examining at least 18 lymph nodes during colon cancer surgery may lead to more accurate staging and improved survival rates, according to research presented at the Society of Surgical Oncology 2025 Annual Meeting.
-
Fox Chase nurse finalist for national Extraordinary Healer award
Matthew Mangold, a nurse at Fox Chase Cancer Center in Philadelphia, has been named one of three finalists for the 2025 Extraordinary Healer award.
-
Fox Chase researcher awarded grant from Uplifting Athletes
Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, has been awarded a research grant from Uplifting Athletes.
-
Temple Health's Dr. Jay Simhan awarded first place at Jackson Hole Seminar
Dr. Jay Simhan, a surgeon at Temple Health and Fox Chase Cancer Center, has been recognized with a first-place award at the 44th Annual Ralph E. Hopkins Jackson Hole Seminar Series in Urology.
-
Fox Chase Cancer Center’s biosample repository earns CAP reaccreditation
Fox Chase Cancer Center's Biosample Repository Facility in Philadelphia has been reaccredited by the College of American Pathologists (CAP) following an on-site inspection.
-
Caryn Karff appointed administrative director at Fox Chase Cancer Center
Fox Chase Cancer Center and Temple University Hospital have announced the appointment of Caryn Karff as the new Administrative Director of Radiology.
-
Dr. Alycia So joins Philadelphia Academy of Surgery as new fellow
Fox Chase Cancer Center's Dr. Alycia So has been inducted as a fellow into the Philadelphia Academy of Surgery, an organization with a long-standing history in advancing surgical practices and public health since its establishment in 1879. Dr. So...
-
Fox Chase Cancer Center earns reaccreditation from FACT
Fox Chase Cancer Center's Department of Bone Marrow Transplant and Cellular Therapy has been reaccredited by the Foundation for the Accreditation of Cellular Therapy (FACT).
-
Prevent Cancer Foundation funds ChatBot development for patient support in genetic testing
Fox Chase Cancer Center's Erin K. Tagai has been awarded a grant by the Prevent Cancer Foundation to create a ChatBot aimed at assisting patients with genetic testing results.
-
Fox Chase researchers explore blocking AKT pathway for potential cancer treatments
Researchers at the Fox Chase Cancer Center have recently released two comprehensive reviews on the role of AKT, also known as protein kinase B, in cancer development and treatment.
-
Study links timely treatment with improved rectal cancer survival rates
Starting treatment for rectal cancer within 60 days of initial evaluation significantly enhances survival rates, according to a recent study by researchers at Fox Chase Cancer Center and Temple Health.
-
Three Fox Chase faculty members recognized among world's most highly cited researchers
Fox Chase Cancer Center has announced that three of its faculty members have been named to the 2024 list of Highly Cited Researchers by Clarivate.
-
Alyssa R. Goldbach joins Fox Chase Cancer Center as assistant professor
Fox Chase Cancer Center and Temple Health have announced the appointment of Alyssa R. Goldbach, DO, as an Assistant Professor for Breast Imaging in the Department of Diagnostic Imaging.
-
Fox Chase Cancer Center appoints Dr. Jason A. Damsker as professor
Fox Chase Cancer Center in Philadelphia has announced the appointment of Dr. Jason A. Damsker as a Professor. Dr. Damsker is board-certified in medical oncology, hematology, and internal medicine.
-
Fox Chase Cancer Center hosts fifth annual cancer epigenetics symposium
Fox Chase Cancer Center is set to host its fifth annual Cancer Epigenetics Symposium on March 6 at the Franklin Institute in Philadelphia.
-
Study finds some kidney cancer patients can pause treatment after two years
A study from Fox Chase Cancer Center suggests that certain patients with metastatic kidney cancer might safely discontinue combination therapy after two years if they respond well to treatment.
-
Fox Chase researchers report promising results for bladder-preserving cancer treatment
Researchers at Fox Chase Cancer Center have presented interim findings from a clinical trial showing promise for treating muscle-invasive bladder cancer.